Ruth S. Kimmelshue left the role of Director at Fuller H B Co. As of November 6, 2026, Fuller H B Co has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 28, 2026, naming 1 appointment and 1 departure (Form 8-K, September 28, 2026).
FULLER H B CO named a new Director on Sep 28. 30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Fuller H B Co? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Fuller H B Co reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-28. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Fuller H B Co files it.
Also on the record for Fuller H B Co
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 14, 2026 | Stake report, Schedule 13G, by Dimensional Fund Advisors LP | 5.3% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.22% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 6.91% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 14.4% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Fuller H B Co now and the warning signs.
Free to see. No signup.
Keep reading
More on Fuller H B Co and the records around it.
Fuller H B Co elsewhere on the record
Companies that share a holder
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
Watch Fuller H B Co
Get an email when Fuller H B Co files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Fuller H B Co?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Fuller H B Co: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fuller H B Co covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-28 | Out | Director | 8-K, 2026-09-28 | ||
| 2026-09-28 | In | Director | 2026-09-23 | 8-K, 2026-09-28 |
Who leads Fuller H B Co, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Ruth S. Kimmelshue, departure reported (filed 2026-09-28). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Fuller H B Co: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Fuller H B Co, with the record behind each one.
Find candidates like Director at Fuller H B CoEvery change, in the filing's words
Departing: Ruth S. Kimmelshue, Director
(b) On September 23, 2026, Ruth S. Kimmelshue notified H.B. Fuller Company (the "Company") of her resignation as a member of the Board of Directors ("Board") of the Company, effective immediately.
Appointed: R. Jeffrey Bailly, Director, effective 2026-09-23
(d) On September 23, 2026, the Board elected R. Jeffrey Bailly, age 64, as a Class I director of the Company, effective September 23, 2026, for an initial term expiring at the Company's 2027 annual meeting of shareholders.
- Departure of Dir e ctors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- Ms. Kimmelshue's retirement as a director of the Company is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- The Company thanks Ms. Kimmelshue for her dedication, commitment, and extraordinary service and wishes her continued success in all her future endeavors.
- Mr. Bailly also has been appointed to serve on the Audit Committee and the Compensation Committee of the Board.
- Since June 2026, Mr. Bailly has served as the Executive Chairman of the Board of UFP Technologies, Inc. ("UFP Technologies"), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices.
- Prior to being named Executive Chairman of the Board, he served as Chief Executive Officer of UFP Technologies since 1995 and as its Chairman of the Board since 2006.
- Mr. Bailly brings more than three decades of executive leadership experience spanning business transformation, M&A, manufacturing, and medical technology.
- As CEO of UFP Technologies from 1995 to 2026, he led the transformation of the company into a leading global contract development and manufacturing organization focused on higher growth, higher margin medical end markets.
Tools for this story
Each opens in a new tab, filled in for Fuller H B Co. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.